ORIC Pharmaceuticals Inc. (ORIC)
NASDAQ: ORIC
· Real-Time Price · USD
9.72
-0.21 (-2.11%)
At close: Aug 15, 2025, 3:59 PM
9.62
-1.03%
After-hours: Aug 15, 2025, 07:13 PM EDT
ORIC Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | 1.07M | n/a | n/a | n/a | 1.54M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 310K | 302K | 533K | 270K | 272K | 261K | 263K | 257K | 259K | 253K | 247K | 221K | 247K | 251K | 229K | 217K | 222K | 229K |
Gross Profit | -310K | -302K | 533K | -270K | -272K | -261K | 1.27M | -257K | -259K | -253K | -247K | -221K | -247K | -251K | -229K | -217K | -222K | -229K |
Operating Income | -39.06M | -32.72M | -39.57M | -38.32M | -36.02M | -28.99M | -31.43M | -28.68M | -24.99M | -25.68M | -22.12M | -25.69M | -20.7M | -23.26M | -22.8M | -18.46M | -21.06M | -16.55M |
Interest Income | n/a | n/a | n/a | n/a | 4.05M | 3.98M | 3.1M | 3.2M | 2.05M | 1.73M | 1.27M | 865K | 409K | 99K | 34K | 30K | 33K | 44K |
Pretax Income | -36.35M | -30.02M | -36.31M | -34.57M | -31.96M | -25.01M | -28.33M | -25.48M | -22.94M | -23.95M | -20.85M | -24.83M | -20.29M | -23.16M | -22.77M | -18.43M | -21.01M | -16.51M |
Net Income | -36.35M | -30.02M | -36.31M | -34.57M | -31.96M | -25.01M | -28.33M | -25.48M | -22.94M | -21.96M | -19.57M | -23.96M | -20.29M | -23.06M | -22.77M | -18.43M | -21.01M | -16.51M |
Selling & General & Admin | 8.52M | 8.08M | 7.6M | 7.12M | 7.08M | 6.77M | 6.68M | 6.29M | 6.21M | 6.16M | 5.82M | 5.97M | 6.86M | 6.43M | 6.06M | 5.56M | 5.54M | 4.86M |
Research & Development | 30.55M | 24.64M | 31.97M | 31.2M | 28.94M | 21.96M | 24.48M | 22.39M | 18.79M | 19.52M | 16.3M | 14.72M | 13.83M | 16.83M | 16.75M | 12.9M | 15.52M | 11.7M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | 263K | n/a | 2.05M | n/a | 5M | 5M | 409K | n/a | n/a | n/a | 15K | n/a |
Operating Expenses | 39.06M | 32.72M | 39.57M | 38.32M | 36.02M | 28.73M | 31.43M | 28.68M | 24.99M | 25.68M | 22.12M | 20.69M | 20.7M | 23.26M | 22.8M | 18.46M | 21.06M | 16.55M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | 1.99M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | -261K | -263K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 39.06M | 32.72M | 39.57M | 38.32M | 36.02M | 28.99M | 31.43M | 28.68M | 24.99M | 25.68M | 22.12M | 20.69M | 20.7M | 23.26M | 22.8M | 18.46M | 21.06M | 16.55M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 136.91K | -1.99M | -1.27M | -865K | n/a | -99K | -34K | -30K | -33K | -88K |
Shares Outstanding (Basic) | 78.13M | 71.04M | 70.65M | 70.54M | 70.35M | 67.35M | 57.46M | 57.4M | 45.65M | 45.09M | 40.18M | 39.58M | 39.48M | 39.43M | 39.39M | 39.01M | 36.7M | 36.68M |
Shares Outstanding (Diluted) | 78.13M | 71.04M | 70.65M | 70.54M | 70.35M | 67.35M | 57.46M | 57.4M | 45.65M | 45.09M | 40.18M | 39.58M | 39.48M | 39.43M | 39.39M | 39.01M | 36.7M | 36.68M |
EPS (Basic) | -0.47 | -0.42 | -0.51 | -0.49 | -0.45 | -0.37 | -0.49 | -0.44 | -0.5 | -0.49 | -0.49 | -0.61 | -0.51 | -0.58 | -0.58 | -0.47 | -0.57 | -0.45 |
EPS (Diluted) | -0.47 | -0.42 | -0.51 | -0.49 | -0.45 | -0.37 | -0.49 | -0.44 | -0.5 | -0.49 | -0.49 | -0.61 | -0.51 | -0.58 | -0.58 | -0.47 | -0.57 | -0.45 |
EBITDA | -39.06M | -32.72M | -39.27M | -38.05M | -35.74M | -28.73M | -31.16M | -28.43M | -24.73M | -25.43M | -21.87M | -20.47M | -20.45M | -23.01M | -22.58M | -18.24M | -20.84M | -16.32M |
EBIT | -36.35M | -30.02M | -36.31M | -38.32M | -36.02M | -28.99M | -31.43M | -28.68M | -24.99M | -25.68M | -22.12M | -20.69M | -20.7M | -23.26M | -22.8M | -18.46M | -21.06M | -16.55M |
Depreciation & Amortization | n/a | 302K | 304K | 270K | 272K | 261K | 263K | 257K | 259K | 253K | 247K | 221K | 247K | 251K | 229K | 217K | 222K | 229K |